196 related articles for article (PubMed ID: 18383741)
1. [Primary central nervous system lymphoma--a single center experience].
Mitrović Z; Radman I; Aurer I; Petranović D; Santek F; Labar B
Lijec Vjesn; 2007 Dec; 129(12):391-5. PubMed ID: 18383741
[TBL] [Abstract][Full Text] [Related]
2. Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
Plotkin SR; Betensky RA; Hochberg FH; Grossman SA; Lesser GJ; Nabors LB; Chon B; Batchelor TT
Clin Cancer Res; 2004 Sep; 10(17):5643-6. PubMed ID: 15355887
[TBL] [Abstract][Full Text] [Related]
3. Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.
Kiewe P; Fischer L; Martus P; Thiel E; Korfel A
Cancer; 2008 Apr; 112(8):1812-20. PubMed ID: 18318432
[TBL] [Abstract][Full Text] [Related]
4. Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis.
Schuurmans M; Bromberg JE; Doorduijn J; Poortmans P; Taphoorn MJ; Seute T; Enting R; van Imhoff G; van Norden Y; van den Bent MJ
Br J Haematol; 2010 Oct; 151(2):179-84. PubMed ID: 20738305
[TBL] [Abstract][Full Text] [Related]
5. Advances for the treatment of primary central nervous system lymphoma (review).
Yamanaka R; Tanaka R
Oncol Rep; 2004 Sep; 12(3):563-8. PubMed ID: 15289838
[TBL] [Abstract][Full Text] [Related]
6. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.
Ekenel M; Iwamoto FM; Ben-Porat LS; Panageas KS; Yahalom J; DeAngelis LM; Abrey LE
Cancer; 2008 Sep; 113(5):1025-31. PubMed ID: 18618509
[TBL] [Abstract][Full Text] [Related]
7. [Primary central nervous system lymphomas].
Hrudková M; Belada D; Smolej L; Zák P; Malý J
Vnitr Lek; 2010 Aug; 56(8):795-800. PubMed ID: 20845611
[TBL] [Abstract][Full Text] [Related]
8. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.
Hormigo A; Abrey L; Heinemann MH; DeAngelis LM
Br J Haematol; 2004 Jul; 126(2):202-8. PubMed ID: 15238140
[TBL] [Abstract][Full Text] [Related]
9. Primary CNS lymphoma.
Gerstner E; Batchelor T
Expert Rev Anticancer Ther; 2007 May; 7(5):689-700. PubMed ID: 17492932
[TBL] [Abstract][Full Text] [Related]
10. Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.
Korfel A; Martus P; Nowrousian MR; Hossfeld DK; Kirchen H; Brücher J; Stelljes M; Birkmann J; Peschel C; Pasold R; Fischer L; Jahnke K; Thiel E;
Br J Haematol; 2005 Jan; 128(2):177-83. PubMed ID: 15638851
[TBL] [Abstract][Full Text] [Related]
11. Patterns of treatment in older adults with primary central nervous system lymphoma.
Panageas KS; Elkin EB; Ben-Porat L; Deangelis LM; Abrey LE
Cancer; 2007 Sep; 110(6):1338-44. PubMed ID: 17647247
[TBL] [Abstract][Full Text] [Related]
12. Results of treatment of 112 cases of primary CNS lymphoma.
Yamanaka R; Morii K; Shinbo Y; Homma J; Sano M; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Kakuma T; Tanaka R
Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337
[TBL] [Abstract][Full Text] [Related]
13. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.
Haldorsen IS; Krossnes BK; Aarseth JH; Scheie D; Johannesen TB; Mella O; Espeland A
Cancer; 2007 Oct; 110(8):1803-14. PubMed ID: 17721992
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.
Gavrilovic IT; Hormigo A; Yahalom J; DeAngelis LM; Abrey LE
J Clin Oncol; 2006 Oct; 24(28):4570-4. PubMed ID: 17008697
[TBL] [Abstract][Full Text] [Related]
15. Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group).
O'Brien PC; Roos DE; Pratt G; Liew KH; Barton MB; Poulsen MG; Olver IN; Trotter GE;
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):408-13. PubMed ID: 16198065
[TBL] [Abstract][Full Text] [Related]
16. Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphoma.
Gerber DE; Grossman SA; Batchelor T; Ye X
Cancer Chemother Pharmacol; 2007 May; 59(6):817-23. PubMed ID: 16972068
[TBL] [Abstract][Full Text] [Related]
17. [Intraocular non-Hodgkin's lymphoma and its therapy-- a case series of ten patients].
Siepmann K; Rohrbach JM; Duncker G; Zierhut M
Klin Monbl Augenheilkd; 2004 Apr; 221(4):266-72. PubMed ID: 15118956
[TBL] [Abstract][Full Text] [Related]
18. Controversies in primary CNS lymphoma.
Abrey LE
Expert Rev Neurother; 2005 Jul; 5(4):459-64. PubMed ID: 16026229
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
Bierman P; Giglio P
Hematol Oncol Clin North Am; 2005 Aug; 19(4):597-609, v. PubMed ID: 16083825
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.
Green MR; Chowdhary S; Lombardi KM; Chalmers LM; Chamberlain M
Expert Rev Neurother; 2006 May; 6(5):635-52. PubMed ID: 16734512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]